生物启发的工程病毒模拟囊泡,用于增强毒激进剂的细胞溶液输送到状细胞中
Shi-Zhen Geng1, Yaru Shi2, Jinjin Yang1
1Department of Anesthesiology, Pain and Perioperative Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, P. R. China.
Advanced materials (Deerfield Beach, Fla.)
|February 10, 2026
概括
一个新的登革热病毒模拟平台 (CDN@VLP) 精确地将STING激动剂传递给树突细胞 (DCs),增强疗效和减少副作用,改善癌症免疫疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 纳米技术 纳米技术
- 病毒学 病毒学
背景情况:
- 将STING激动剂有效地输送到树突细胞 (DCs) 对于癌症免疫疗法至关重要.
- 目前的循环二核酸 (CDN) 疗法面临的挑战是,细胞质递送效率低下和T细胞耗尽.
研究的目的:
- 设计一个登革热病毒模拟平台 (CDN@VLP) 以精确地向DCs提供STING激动剂.
- 克服当前CDN疗法的局限性,提高特异性和减少非目标效应.
主要方法:
- 设计了一个高保真,登革热病毒模拟病毒样粒子 (VLP) 平台 (CDN@VLP).
- 与脂质纳米颗粒相比,评估了DC特异性吸收,T细胞内化和抗瘤功效.
- 确定了cDC1积累和I型干扰素反应的最佳VLP亚型.
- 进行了转录基因分析,以调查作用机制.
主要成果:
- CDN@VLP增强了1.9倍的DC特定吸收,并减少了14.8倍的瘤T细胞内部化.
- 在1/40的免费CDN的剂量达到可比的抗瘤疗效.
- 优化的VLP使cDC1的积累提高了2.3倍,IFN-β的产生增加了12.8倍.
- CDN@VLP通过化学激素分泌 (XCL1,CCL4,CCL5) 促进了cDC1的招募.
结论:
- CDN@VLP平台通过模仿病毒热流,使精确的STING激活成为可能.
- 这种方法克服了cDC1向免疫治疗中的强度特异性权衡.
- CDN@VLP代表了先进癌症免疫治疗的有希望的策略.
相关概念视频
What are Viruses?
128.4K
Overview
128.4K
Neurons: The Cell Body and the Dendrites
7.3K
A typical nerve cell comprises three main components: the cell body, dendrites, and the axon. The cell body, also known as the soma or perikaryon, serves as the central biosynthetic hub housing a nucleus surrounded by cytoplasm containing organelles commonly found in most cells. Notably, Nissl bodies, clusters of the rough endoplasmic reticulum and free ribosomes responsible for protein synthesis, are distinctive features of the neuronal cell body. As neurons age, aggregates of a brown pigment...
7.3K
Adrenergic Agonists: Therapeutic Uses
2.0K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.0K
Glucagon-like Receptor Agonists
1.0K
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
1.0K
What is Genetic Engineering?
80.4K
Overview
80.4K
Drug-Receptor Interaction: Agonist
4.1K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.1K


